u/ismael_chukwu

That reads as a warning about a documented supplier and the events you describe are about a shop nobody has any record of.

Questions about oral contraceptive absorption and gastric emptying are legitimate pharmacology questions with product-specific answers. A pharmacist can answer them properly; a board cannot.

Bacteriostatic water contains a preservative, which is what makes repeated entry into a vial reasonable. Sterile water does not, and the two are not interchangeable for that purpose.

Research-use-only material is not approved for human use. In this board that is not a formality — it is the reason the clinical evidence base is as thin as it is.

Is that from a human study or a preclinical model?

Asked a pharmacist about the absorption question rather than the internet. Ten minutes, clear answer, done.

Cosigning that going too fast is the most repeated regret on the whole site.

the central appetite effect is doing more work than the gut effect

Regulatory classification differs between jurisdictions and has changed in several of them recently. Any answer to a status question needs a place and a date attached.

Careful with naming anybody. The board rule holds even here, and especially here.

identity testing matters more here than purity does

Research-use-only material is not approved for human use. That is a plain statement of regulatory fact and it belongs in every beginner thread.

The weekly interval comes out of the half-life — roughly a week — so you are on a smooth curve rather than a series of spikes. That is also why moving your day slightly does very little.

Right, and stopping for money reasons is not a failure of anything. It is a budget.

I would not generalise from one bad month to a rule. The rest of your process sounds fine.

the central appetite effect is doing more work than the gut effect

Cosigning. The appetite change and the scale change ran about three weeks apart for me too.

dose day drift of a day either way is fine, the curve barely notices

Adding one thing to this: the appetite effect and the scale run on separate clocks, so both halves can be true at once.

Has anyone posted an independent result on that batch?

Concentration is mass over volume, and a U-100 syringe reads 100 units per millilitre. Those two facts are the whole of the arithmetic this board keeps explaining.

the appetite signal and the scale move on different clocks

constipation made the first fortnight rough at each step up, then flattened out. Predictable enough that I started planning around it.

What dose and how many weeks at it before this started?

PCOS is a diagnosis, not a description, and it matters which you mean

Cosigning on GIP. The genuinely interesting thing is that the biology is not settled and the clinical result is nonetheless robust.

Appetite change and weight change are different measurements on different timescales. The first is usually noticed first and the second lags it.

A certificate of analysis is a document describing one batch: what was tested, by what method, and what the result was. Its value depends entirely on whether it names the batch and the method.

Small fix — fifteen residues, not seventeen. The sequence is public and easy to check.

ask the dumb question, three other people are searching for it

Yes. Nothing here is approved for human use and that should be the first line of every thread, not the last.

Regulatory classification differs between jurisdictions and has changed in several of them recently. Any answer to a status question needs a place and a date attached.

Not convinced. A high purity figure with no identity confirmation tells you the sample is homogeneous, not that it is what you ordered.

if 2.4mg is working there is no prize for going up

What jurisdiction are you asking about? The answer has changed in several.

no question is too basic here, that is the entire point of the board

Week 18 for me was completely flat and I was convinced something was wrong.

This is the answer. Everything else in the thread is elaboration on it.

Glucose-dependent insulin secretion is why hypoglycaemia risk is low as monotherapy: the effect scales with glycaemia rather than acting unconditionally.